Citation:Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M 1992
From Cancer Guidelines Wiki
Citation
Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992 Sep;33(9):1155-8 Available from: http://www.ncbi.nlm.nih.gov/pubmed/1427364.
Critical appraisals
Compare quality appraisals for each clinical question
- [[Clinical question:What is the incidence of neoplasia in patients with BO?|Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the incidence of neoplasia in patients with BO?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:Are there groups of patients with non-dysplastic BO that require more frequent surveillance?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Are there groups of patients with non-dysplastic BO that require more frequent surveillance?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:Are there groups of patients with BO that can be discharged from surveillance?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Are there groups of patients with BO that can be discharged from surveillance?</span></span></span></span>»]] (compare critical appraisals)